186 related articles for article (PubMed ID: 18803262)
1. Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA.
Beisner J; Dong M; Taetz S; Piotrowska K; Kleideiter E; Friedel G; Schaefer U; Lehr CM; Klotz U; Mürdter TE
J Pharm Sci; 2009 May; 98(5):1765-74. PubMed ID: 18803262
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells.
Beisner J; Dong M; Taetz S; Nafee N; Griese EU; Schaefer U; Lehr CM; Klotz U; Mürdter TE
Lung Cancer; 2010 Jun; 68(3):346-54. PubMed ID: 19695733
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
4. Treatment of lung cancer via telomerase inhibition: self-assembled nanoplexes versus polymeric nanoparticles as vectors for 2'-O-Methyl-RNA.
Nafee N; Schneider M; Friebel K; Dong M; Schaefer UF; Mürdter TE; Lehr CM
Eur J Pharm Biopharm; 2012 Apr; 80(3):478-89. PubMed ID: 22198416
[TBL] [Abstract][Full Text] [Related]
5. Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2'-O-methyl-RNA.
Dong M; Philippi C; Loretz B; Nafee N; Schaefer UF; Friedel G; Ammon-Treiber S; Griese EU; Lehr CM; Klotz U; Mürdter TE
Int J Pharm; 2011 Oct; 419(1-2):33-42. PubMed ID: 21782910
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells.
Tamura Y; Tao M; Miyano-Kurosaki N; Takai K; Takaku H
Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):87-96. PubMed ID: 10805159
[TBL] [Abstract][Full Text] [Related]
7. Delivery of phosphodiester oligonucleotides: can DOTAP/DOPE liposomes do the trick?
Remaut K; Lucas B; Braeckmans K; Sanders NN; Demeester J; De Smedt SC
Biochemistry; 2006 Feb; 45(6):1755-64. PubMed ID: 16460022
[TBL] [Abstract][Full Text] [Related]
8. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T
Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cationic dendrimer and lipid as transfection reagents of short RNAs for stem cell modification.
Ziraksaz Z; Nomani A; Soleimani M; Bakhshandeh B; Arefian E; Haririan I; Tabbakhian M
Int J Pharm; 2013 May; 448(1):231-8. PubMed ID: 23535347
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of two kinds of cationic vectors-mediated gene delivery].
Zhi DF; Wang B; Cui SH; Yang BL; Zhao BD; Zhao YN; Jiang YX; Yu SJ; Zhang SB
Yao Xue Xue Bao; 2009 May; 44(5):553-7. PubMed ID: 19618735
[TBL] [Abstract][Full Text] [Related]
11. Pyridinium cationic lipids in gene delivery: an in vitro and in vivo comparison of transfection efficiency versus a tetraalkylammonium congener.
Ilies MA; Johnson BH; Makori F; Miller A; Seitz WA; Thompson EB; Balaban AT
Arch Biochem Biophys; 2005 Mar; 435(1):217-26. PubMed ID: 15680924
[TBL] [Abstract][Full Text] [Related]
12. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.
Li H; Hao Y; Wang N; Wang L; Jia S; Wang Y; Yang L; Zhang Y; Zhang Z
Drug Deliv; 2016; 23(3):840-8. PubMed ID: 24892622
[TBL] [Abstract][Full Text] [Related]
13. DOTAP/UDCA vesicles: novel approach in oligonucleotide delivery.
Ruozi B; Battini R; Montanari M; Mucci A; Tosi G; Forni F; Vandelli MA
Nanomedicine; 2007 Mar; 3(1):1-13. PubMed ID: 17379164
[TBL] [Abstract][Full Text] [Related]
14. The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells.
Taetz S; Nafee N; Beisner J; Piotrowska K; Baldes C; Mürdter TE; Huwer H; Schneider M; Schaefer UF; Klotz U; Lehr CM
Eur J Pharm Biopharm; 2009 Jun; 72(2):358-69. PubMed ID: 18703137
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.
Glukhov AI; Zimnik OV; Gordeev SA; Severin SE
Biochem Biophys Res Commun; 1998 Jul; 248(2):368-71. PubMed ID: 9675142
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)].
Ma XB; Han WD; Hao HJ; Li Q; Xu ZM; Lu XC; Zhao YL
Ai Zheng; 2003 Sep; 22(9):932-7. PubMed ID: 12969524
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibitory activity of chimeric oligonucleotides targeting two different sites of human telomerase.
Matthes E; Lehmann C; Stulich M; Wu Y; Dimitrova L; Uhlmann E; Janta-Lipinski MV
Oligonucleotides; 2005 Dec; 15(4):255-68. PubMed ID: 16396620
[TBL] [Abstract][Full Text] [Related]
18. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids.
Zelphati O; Szoka FC
Pharm Res; 1996 Sep; 13(9):1367-72. PubMed ID: 8893276
[TBL] [Abstract][Full Text] [Related]
19. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
Lei LX; Chen ZD
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomes.
Kawakami S; Suzuki S; Yamashita F; Hashida M
J Control Release; 2006 Feb; 110(3):514-21. PubMed ID: 16360957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
